DOCSLIB.ORG

Toma, 539 Acinic Cell Carcinoma Mucinous Adenocarcinoma Vs., 334

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Toma, 539 Acinic Cell Carcinoma Mucinous Adenocarcinoma Vs., 334 Cambridge University Press 978-0-521-87999-6 - Head and Neck Margaret Brandwein-Gensler Index More information INDEX acanthomatous/desmoplastic ameloblas- ameloblastomas benign neoplasia toma, 539 desmoplastic ameloblastoma, 539 juvenile nasopharyngeal angiofibroma, acinic cell carcinoma metastasizing ameloblastoma, 537 99–104 mucinous adenocarcinoma vs., 334–335 mural ameloblastoma, 533 salivary gland anlage tumor, 104–106 oncocytoma vs., 295–299 odonto-ameloblastoma, 551–553 benign peripheral nerve sheath tumors papillary cystic variant, vs. cystade- peripheral ameloblastoma, 534 (BPNST), 40–44 noma, 316–317 unicystic ameloblastoma, 532–533 benign sinonasal tract neoplasia, 28–48 salivary glands, 353–359 aneurysmal bone cyst (ABC), 584 benign peripheral nerve sheath tumor, adenocarcinoma not otherwise specified central GCRG vs., 590–591 40–44 (ANOS), 389–390 angiocentric T-cell lymphoma, 81 meningioma, 37–40 adenoid cystic carcinoma (ACC) angiomatoid/angioectatic polyps vs. JNAF, nasal glial heterotopia (NGH), 44–48 adenomatoid odontogenic tumor vs., 100–104 oncocytic Schneiderian papilloma 545 angiosarcoma vs. Kaposi’s sarcoma, 206 (OSP), 5, 33–36 basal cell adenocarcinoma vs., 372 antrochoanal polyp, 5–8 Schneiderian inverted papilloma, 28–32 basal cell adenoma vs., 293 apical periodontal cyst, 510–512 bisphosphonate osteonecrosis (BPP), canalicular adenoma vs., 294 arytenoid chondrosarcomas, 241 565–566 neuroendocrine carcinoma vs., 240–241 atrophic oral lichen planus, 126 blastomas of salivary glands, 319–325 atypical adenoma vs. parathyroid carci- ameloblastoma, 524–532 PLGA vs., 363–365 noma, 499–501 cementoblastoma, 563–564, 598–600 adenoma cystic carcinoma (ACC), 279– autoimmune thyroid disease. See Hashi- desmoplastic ameloblastoma, 539 283 moto’s thyroiditis laryngeal blastomas, 256 adenomatoid odontogenic tumor (AOT), metastasizing ameloblastoma, 537 542–545 balloon cell nevus, 145 mural ameloblastoma, 533 adenosquamous carcinoma, 334–335 basal cell adenocarcinoma odonto-ameloblastoma, 551–553 adult onset laryngeal papillomas (AOLP), adenoid cystic carcinoma vs., 324– osteoblastoma (giant osteoid osteoma), 227 325 597–600 adult rhabdomyoma vs. hamartoma, 225 ameloblastoma vs., 532 peripheral ameloblastoma, 534 adult-type rhabdomyoma, 168 basal cell adenoma vs., 293 sialoblastoma, 382–384 African Americans of salivary glands, 369–373 unicystic ameloblastoma, 532–533 florid cemento-osseous dysplasia, 569 basal cell adenoma (BCA) blue nevi (oral), 145 focal cemento-osseous dysplasia, 569 basal cell adenocarcinoma vs., 372 botryoid odontogenic cyst (BOC), 513 granular cell tumors, 165 canalicular adenoma vs., 294 glandular odontogenic cyst vs., 516– periapical cemento-osseous dysplasia, salivary glands, 286–293 517 568–569 basal cell nevus syndrome, 517 branchial cleft cysts AIDS-related parotid cysts (ARPCs), 308– basaloid squamous cell carcinoma (BSCC) described, 220 311 adenoid cystic carcinoma vs., 325 saccular cyst vs., 219 Aleurites fordii, 108 basal cell adenocarcinoma vs., 372 brown tumor of hyperparathyroidism allergic fungal sinusitis (AFS), 8–15 benign lymphoepithelial lesion (BLEL) of central GCRG vs., 590–591 amalgam tattoo, 136 salivary glands, 308 giant cell tumor vs., 593–595 ameloblastic carcinoma, 534–537 benign migratory glossitis. See geographic bullous oral lichen planus, 126 ameloblastic fibro-odontoma, 547–550 tongue bullous pemphigoid, 129–130 ameloblastic fibrodentinoma, 547 benign mixed tumor (BMT) Burkitt’s lymphoma, 108 ameloblastic fibroma, 545–547 myoepithelioma vs., 314 ameloblastic odontoma, 551–553 SSPA vs., 304–306 calcified cystic odontogenic tumor ameloblastoma, 524–532 benign mucosal pemphigoid, 129–130 (CCOT), 553–554 623 © in this web service Cambridge University Press www.cambridge.org Cambridge University Press 978-0-521-87999-6 - Head and Neck Margaret Brandwein-Gensler Index More information INDEX calcifying epithelial odontogenic tumor cicatricial pemphigoid, 129–130 cystadenoma vs., 316–317 (CEOT), 539–542 clear cell acinic cell carcinoma, 358–359 dyshormonogenetic goiter, 417–420 canalicular adenoma (of salivary glands), clear cell carcinoma (of salivary glands), dysplasias, 31 293–295 365–366 cemento-fibro-osseous dysplasias, 566– Candida albicans, 128, 151 clear cell chondrosarcoma, 245 578 candida, oral candidiasis (thrush), 153–155 clear cell hyalinizing carcinoma vs. muci- fibrous dysplasia, 569–575 capillary hemangiomas/pyogenic granu- nous adenocarcinoma, 334–335 florid cemento-osseous dysplasia, loma clear cell odontogenic carcinoma (CCOC), 569 contact ulcers vs., 216 559–561 focal cemento-osseous dysplasia, carcinoid tumors. See also well-differenti- clear cell variant (of PTC), 457–458 569 ated neuroendocrine carcinoma Coccicidiodomyces, 20 hereditary cemento-osseous dyspla- (WDNEC) columnar cell variant of PTC (CCV-PTC), sia, 575–578 laryngeal, 299 446–448 periapical cemento-osseous dyspla- vs. oncocytoma, 295–299 tall-cell variant of PTC vs., 442 sia, 568–569 paraganglioma vs., 231 compound oral nevus, 145 mild, low-grade/OIN-1, 173 carcinoma with thymus-like features condyloma moderate/OIN-2, 173 (CASTLE), 488–489 focal epithelial hyperplasia vs., 149 monostotic fibrodysplasia, 571 carcinoma-ex-pleomorphic adenoma genital condyloma, 227 polyostotic fibrodysplasia, 571 (Ca-ex-PA) laryngeal papillomatosis vs., 228 severe/OIN-3, 173 of salivary glands, 335–339 congenital epulis (of newborn), 166–167 pleomorphic adenoma vs., 279–283 craniofacial fibrodysplasia, 572 encapsulated follicular variant of papillary cemento-fibro-osseous dysplasias, 566–578 craniopharyngioma, 532 thyroid carcinoma (EFV-PTC), fibrous dysplasia, 569–575 cribriform morula variant (of PTC), 456– 439 florid cemento-osseous dysplasia, 569 457 follicular adenoma vs., 423–425 focal cemento-osseous dysplasia, 569 Croton macrostachyus, 108 encapsulated salivary sclerosing polycystic hereditary cemento-osseous dysplasia, Croton megalocarpus, 108 adenosis, 304–306 575–578 Croton tiglium, 108 encapsulated variant (of PTC), 436 periapical cemento-osseous dysplasia, cystadenocarcinoma eosinophilic mucin rhinosinusitis (EMRS), 11 568–569 cystadenoma vs., 316–317 epidermolysis bullosa acquisita vs. pem- cemento-ossifying fibroma, 578–583 low-grade salivary duct carcinoma vs., phigoid (oral), 130 FCOD vs., 569 350–351 epiglottic chondrosarcomas, 241 fibrous dysplasia vs., 575 mucinous adenocarcinoma vs., 389 epiglottic tumors, 233 cementoblastoma, 563–564 of salivary glands, 376–380 epithelial myoepithelial carcinoma osteoblastoma vs., 598–600 cystadenoma myoepithelial carcinoma vs., 376 central giant cell reparative granuloma cystadenocarcinoma vs., 316–317, 379– of salivary glands, 366–369 (GCRG), 584–592 380 Epstein-Barr virus (EBV) central low-grade mucoepidermoid carci- salivary glands, 316–317 associations noma (CMEC), 516–517 cystic fibrosis and nasal polyps, 4 lymphoepithelial carcinoma, 387 chondroblastic osteosarcoma vs. chondro- NK/T-cell SNL, 81 sarcoma, 617 dedifferentiated chondrosarcoma, 245 Sjo¨gren’s/DLIS, 308 chondromas, 609–610 dentigerous cysts (follicular cyst), 513– hairy leukoplakia and, 150 osteochondroma, 595–597 516 risk factor, for NPC, 107 vs. chondrometaplasia, 222 dentinogenic ghost cell tumor (DGCT), erosive oral lichen planus, 126 chondrometaplasia 557–559 pemphigoid (oral) vs., 130 chondrosarcoma vs., 245 DeQuervain’s thyroiditis. See subacute erythroleukoplakia, 170 hamartoma vs., 225 (DeQuervain’s) thyroiditis Eskimo tumor. See lymphoepithelial carci- chondrosarcoma (CS), 610–617 differential diagnosis noma clear cell, 245 meningioma, 40 Euphorbia lathyris, 108 dedifferentiated, 245 nasal glial heterotopia (NGH), 47 exotic laryngeal papillomas, 226–227 epiglottic, 241 oncocytic Schneiderian papilloma, 36 hyoid, 242 Schneiderian inverted papilloma, 32 FCOD. See focal cemento-osseous dyspla- laryngeal, 241–245 diffuse infiltrative lymphocytosis (DILS), sia (FCOD) mesenchymal, 616 308–311 fetal-type rhabdomyoma, 169 chordomas, 617 diffuse large cell lymphoma, 117 fibromas chronic hyperplastic candidiasis, 154 diffuse sclerosing variant of PTC (DSV- ameloblastic fibroma, 545–547 chronic sclerosing sialoadenitis (CSS), 264 PTC), 458 cemento-ossifying fibroma, 578–583 chronic sialadenitis/sialolithiasis, 264–265 dysgenetic polycystic disease, 272–274 FCOD vs., 569 624 © in this web service Cambridge University Press www.cambridge.org Cambridge University Press 978-0-521-87999-6 - Head and Neck Margaret Brandwein-Gensler Index More information INDEX fibrous dysplasia vs., 575 Gorlin’s cyst, 553–554 focal epithelial hyperplasia, 149 oral cavity, 156–159 Gorlin’s syndrome, 517 gingival pseudoepitheliomatous hyper- ossifying fibroma, 583 Gorlin-Goltz syndrome, 517 plasia, 539 fibrosarcoma, 245 granular cell tumor (GCT), 165–167 recurrent parathyroid hyperplasia, 499– HPC vs., 70 Grave’s disease (GD), 404–409 501 fibrous dysplasia (FD), 569–575 dyshormonogenetic goiter vs., 419–420 hypertrophic papillary sinusitis, 32 ossifying fibroma vs., 583 REAH vs., 32 florid cemento-osseous dysplasia, 569 hairy leukoplakia. See oral hairy leukopla- Schneiderian inverted papilloma vs., 32 florid papillomatosis, 227 kia (OHL) hypopharyngeal liposarcomas, 254 focal atypia, 44 hairy tongue (HT) hypothyroidism, 213 focal cemento-osseous dysplasia (FCOD), OHL vs., 151 congenital hypothyroidism, 417 569 Hashimoto’s thyroiditis, 402–404, 458 Hashimoto’s thyroiditis and, 402, 403 focal epithelial hyperplasia (FEH/Heck’s dyshormonogenetic goiter vs., 419–420 vocal cord nodules/polyps vs., 215 disease), 147–149 lithium toxicity
Load more

Recommended publications
  • Optimal Management of Common Acquired Melanocytic Nevi (Moles): Current Perspectives
    Clinical, Cosmetic and Investigational Dermatology Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Optimal management of common acquired melanocytic nevi (moles): current perspectives Kabir Sardana Abstract: Although common acquired melanocytic nevi are largely benign, they are probably Payal Chakravarty one of the most common indications for cosmetic surgery encountered by dermatologists. With Khushbu Goel recent advances, noninvasive tools can largely determine the potential for malignancy, although they cannot supplant histology. Although surgical shave excision with its myriad modifications Department of Dermatology and STD, Maulana Azad Medical College and has been in vogue for decades, the lack of an adequate histological sample, the largely blind Lok Nayak Hospital, New Delhi, Delhi, nature of the procedure, and the possibility of recurrence are persisting issues. Pigment-specific India lasers were initially used in the Q-switched mode, which was based on the thermal relaxation time of the melanocyte (size 7 µm; 1 µsec), which is not the primary target in melanocytic nevus. The cluster of nevus cells (100 µm) probably lends itself to treatment with a millisecond laser rather than a nanosecond laser. Thus, normal mode pigment-specific lasers and pulsed ablative lasers (CO2/erbium [Er]:yttrium aluminum garnet [YAG]) are more suited to treat acquired melanocytic nevi. The complexities of treating this disorder can be overcome by following a structured approach by using lasers that achieve the appropriate depth to treat the three subtypes of nevi: junctional, compound, and dermal. Thus, junctional nevi respond to Q-switched/normal mode pigment lasers, where for the compound and dermal nevi, pulsed ablative laser (CO2/ Er:YAG) may be needed.
    [Show full text]
  • Salivary Gland Pathology 25.Pdf
    k Index 461 Mechanoreceptors, 15 patient history, 284 Melanoma pleomorphic adenoma, 286–290 desmoplastic subtype, 63 polymorphous low-grade adenocarcinoma, 174–175, 306, histopathology, 381 309, 312 lower lip, 380–381 primary lymphomas, 368 metastases, 62–63, 189 radiation therapy, 328 nodular, 379 sites of, 285 Merkel cell tumors, metastases, 62, 63, 375 staging, 193–196 Mesenchymal-epithelial transition (MET), 214 Mixed tumor. See Pleomorphic adenoma(s) Mesenchymal neoplasms, 188 Modified Blair incision, 238, 239 Mesenchymal salivary gland tumors Monomorphic adenoma, 167–169, 290 lymphatic malformations, 398, 400 Monomorphic clear cell tumor, 182 neural tumors, 398, 401, 402 Motion artifacts, 21–22 vascular tumors, 397–398, 397–399 Mouth Messenger ribonucleic acid (mRNA), 208, 209, 209 dry, 141 Metal deposits, brain, 24 ranula, 98, 99, 100 Metallic implants, 21, 22 MRI. See Magnetic resonance imaging (MRI) Metalloproteinases, 142 MRS. See Magnetic resonance spectroscopy (MRS) Metastases, 189 Mucocele, 97, 99, 114, 412 diagnostic imaging, 62–64, 63 Mucoepidermoid carcinoma (MEC), 170–172, 214, 389, distant. See Distant metastases 390, 396, 404 regional. See Regional metastases ADC values, 27 skip, 270 biomarkers, 190, 263 Metastasizing mixed tumor, 182, 289 buccal mucosa, 294 Metastasizing pleomorphic adenoma, 287 children, 297 Methicillin resistant S. aureus (MRSA), acute bacterial clear cell variant, 383 parotitis, 75, 78, 96 diagnostic imaging, 56, 57 k Microliths, 439 fixed to mandible, 277 k Middle ear, aberrant glands, 438 grading,
    [Show full text]
  • Inflammatory Juvenile Compound Conjunctival Nevi. a Clinicopathological Study and Literature Review
    Rom J Morphol Embryol 2017, 58(3):in press R J M E EVIEW AND ASE ERIES Romanian Journal of R C S Morphology & Embryology http://www.rjme.ro/ Inflammatory juvenile compound conjunctival nevi. A clinicopathological study and literature review CLAUDIA FLORIDA COSTEA1,2), MIHAELA DANA TURLIUC3,4), GABRIELA DIMITRIU2), CAMELIA MARGARETA BOGDĂNICI1), ANCA MOŢOC2), MĂDĂLINA ADRIANA CHIHAIA2), CRISTINA DANCĂ2), ANDREI CUCU4), ALEXANDRU CĂRĂULEANU5), NICOLETA DUMITRESCU6), LUCIA INDREI7), ŞERBAN TURLIUC8) 1)Department of Ophthalmology, “Grigore T. Popa” University of Medicine and Pharmacy, Iaşi, Romania 2)2nd Ophthalmology Clinic, “Prof. Dr. Nicolae Oblu” Emergency Clinical Hospital, Iaşi, Romania 3)Department of Neurosurgery, “Grigore T. Popa” University of Medicine and Pharmacy, Iaşi, Romania 4)2nd Neurosurgery Clinic, “Prof. Dr. Nicolae Oblu” Emergency Clinical Hospital, Iaşi, Romania 5)Department of Obstetrics and Gynecology, “Grigore T. Popa” University of Medicine and Pharmacy, Iaşi, Romania 6)4th Year Student, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iaşi, Romania 7)3rd Year Student, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania 8)Department of Psychiatry, “Grigore T. Popa” University of Medicine and Pharmacy, Iaşi, Romania Abstract Aim: The conjunctival nevus affecting children and adolescents is a rare condition and the literature showed only few reports on this issue. The aim of this article is to determine the histopathological features for the correct diagnosis of an inflammatory juvenile compound nevus of the conjunctiva (IJCNC) in order to make the difference between this tumor and other lesions, like conjunctival melanoma or lymphoma, very similar from a gross point of view.
    [Show full text]
  • 2018 Solid Tumor Rules Lois Dickie, CTR, Carol Johnson, BS, CTR (Retired), Suzanne Adams, BS, CTR, Serban Negoita, MD, Phd
    Solid Tumor Rules Effective with Cases Diagnosed 1/1/2018 and Forward Updated November 2020 Editors: Lois Dickie, CTR, NCI SEER Carol Hahn Johnson, BS, CTR (Retired), Consultant Suzanne Adams, BS, CTR (IMS, Inc.) Serban Negoita, MD, PhD, CTR, NCI SEER Suggested citation: Dickie, L., Johnson, CH., Adams, S., Negoita, S. (November 2020). Solid Tumor Rules. National Cancer Institute, Rockville, MD 20850. Solid Tumor Rules 2018 Preface (Excludes lymphoma and leukemia M9590 – M9992) In Appreciation NCI SEER gratefully acknowledges the dedicated work of Dr. Charles Platz who has been with the project since the inception of the 2007 Multiple Primary and Histology Coding Rules. We appreciate the support he continues to provide for the Solid Tumor Rules. The quality of the Solid Tumor Rules directly relates to his commitment. NCI SEER would also like to acknowledge the Solid Tumor Work Group who provided input on the manual. Their contributions are greatly appreciated. Peggy Adamo, NCI SEER Elizabeth Ramirez, New Mexico/SEER Theresa Anderson, Canada Monika Rivera, New York Mari Carlos, USC/SEER Jennifer Ruhl, NCI SEER Louanne Currence, Missouri Nancy Santos, Connecticut/SEER Frances Ross, Kentucky/SEER Kacey Wigren, Utah/SEER Raymundo Elido, Hawaii/SEER Carolyn Callaghan, Seattle/SEER Jim Hofferkamp, NAACCR Shawky Matta, California/SEER Meichin Hsieh, Louisiana/SEER Mignon Dryden, California/SEER Carol Kruchko, CBTRUS Linda O’Brien, Alaska/SEER Bobbi Matt, Iowa/SEER Mary Brandt, California/SEER Pamela Moats, West Virginia Sarah Manson, CDC Patrick Nicolin, Detroit/SEER Lynda Douglas, CDC Cathy Phillips, Connecticut/SEER Angela Martin, NAACCR Solid Tumor Rules 2 Updated November 2020 Solid Tumor Rules 2018 Preface (Excludes lymphoma and leukemia M9590 – M9992) The 2018 Solid Tumor Rules Lois Dickie, CTR, Carol Johnson, BS, CTR (Retired), Suzanne Adams, BS, CTR, Serban Negoita, MD, PhD Preface The 2007 Multiple Primary and Histology (MPH) Coding Rules have been revised and are now referred to as 2018 Solid Tumor Rules.
    [Show full text]
  • Sialoblastoma of the Cheek: a Case Report and Review of the Literature
    MOLECULAR AND CLINICAL ONCOLOGY 4: 925-928, 2016 Sialoblastoma of the cheek: A case report and review of the literature PEERAYUT SITTHICHAIYAKUL1, JULINTORN SOMRAN1, NONGLUK OILMUNGMOOL2, SARAN WORASAKWUTTIPONG3 and NOPPADOL LARBCHAROENSUB4 Departments of 1Pathology, 2Radiology and 3Surgery, Faculty of Medicine, Naresuan University, Phitsanulok 65000; 4Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand Received November 23, 2015; Accepted March 21, 2016 DOI: 10.3892/mco.2016.840 Abstract. Sialoblastoma is a rare salivary gland tumor that basal cell adenoma, basaloid adenocarcinoma, congenital hybrid recapitulates the primitive salivary gland anlage. The authors basal cell adenoma-adenoid cystic carcinoma, and embryoma. herein report a case of sialoblastoma of a minor salivary gland, Sialoblastoma most commonly affects the major salivary glands clinically presenting with progressive enlargement of a mass and is histologically characterized by variably arranged, tight in the cheek of a 1-year-old female infant. Histopathologically, clusters or clumps of basaloid cells and partially formed ductal the mass consisted of tight clusters of basaloid cells and and pseudo‑ductal spaces separated by thin fibrous bands. The partially formed ductal and pseudo-ductal spaces separated overall prognosis of this type of tumor remains controversial. by thin fibrous bands. Immunohistchemical studies demon- Sialoblastoma has a tendency to progress to local invasion, local strated the presence of cytokeratin AE1̸AE3, p63, CD99, recurrence and occasional metastasis. In 1996, according to the α-fetoprotein (AFP) and Hep Par-1 expression in a considerable third series of the Armed Forces Institute of Pathology (AFIP) number of tumor cells. The clinical and pathological charac- classification of salivary gland tumors, sialoblastoma was clas- teristics are presented and relevant literature is reviewed.
    [Show full text]
  • DERMOSCOPY of the MONTH Balloon Cell Nevus – Report of Three Cases
    DERMOSCOPY OF THE MONTH Serbian Journal of Dermatology and Venereology 2019; 11 (3): 99-102 DOI: 10.2478/sjdv-2019-0015 DERMOSCOPY OF THE MONTH Balloon Cell Nevus – Report of Three Cases Andrija JOVIĆ1*, Danijela POPOVIĆ1, Slađana CEKIĆ1, Zorana ZLATANOVIĆ1, Hristina KOCIĆ1, Danica TIODOROVIĆ1,2 1Clinic of Skin and Venereal Diseases, Clinical Center of Niš, Serbia 2Faculty of Medicine, University of Niš, Serbia *Correspondence: Andrija Jović, E-mail: [email protected] UDC 616.5-006.8-076 Abstract The balloon cell nevus is a rare and unusual benign melanocytic lesion characterized histologically by complete or predominant presence of balloon-cell transformed melanocytes. They represent approximately 1.7% of all melanocytic nevi. Three female patients, aged 30, 14 and 7 years, with lesions located on the back and head are included in the presented report. The dermoscopic examination revealed the repetitive dermoscopic features in all three patients: white and yellowish aggregated globules. In conclusion, balloon cell nevi are clinically indistinguish- able from the common nevi. Dermoscopy can be useful in their recognition since balloon cell nevi exhibit some distinct dermoscopic features in a form of aggregated white and/or yellow globules. Key words: Nevus, Pigmented; Dermoscopy; Skin Neoplasms; Melanoma; Case Reports Introduction Case Reports The balloon cell nevus (BCN) is a benign melanocytic lesion characterized histologi- Case 1 cally by complete or predominant presence A 30-year old female patient was referred of large transformed melanocytes known as to our Department for a regular mole examina- ˝balloon cells˝ (1–4). This histological entity tion. The patient had the history of a previous- was first reported by Judalaewitsch a century ly excised dysplastic nevus and positive family ago, in 1901.
    [Show full text]
  • Oral Nevi 25/03/13 10:42
    Oral Nevi 25/03/13 10:42 Medscape Reference Reference News Reference Education MEDLINE Oral Nevi Author: Donald Cohen, DMD, MS; Chief Editor: Dirk M Elston, MD more... Updated: Jan 18, 2012 Background Nevi are benign proliferations of nevus cells located either entirely within the epithelium, in both the epithelium and underlying stroma, or in the subepithelial stroma alone. They are best categorized as hamartomas rather than true neoplasms. Nevi of the oral cavity are usually called mucosal melanocytic nevi or intramucosal nevi. In 1943, Field and Ackermann may have reported the first documented case of an intraoral nevus.[1] Comerford and his coworkers were the first to propose the term intralamina propria nevus.[2] King et al adopted the less anatomically specific term, intramucosal nevus, which clinicians more easily understand.[3] White adults have 10-40 cutaneous nevi on average, but intraoral lesions are rare. On the basis of the histologic location of the nevus cells, cutaneous nevi can be classified into 3 categories. The first category, junctional nevus, is when nevus cells are limited to the basal cell layer of the epithelium. The second category, compound nevus, is used if the cells are in the epidermis and dermis. The third category, intradermal nevus, is when nests of nevus cells are entirely in the dermis. Oral nevi follow the same classification; however, the term intradermal is replaced by intramucosal. Nevi may also be classified as congenital or acquired (see Histologic Findings). Oral acquired melanocytic nevi evolve through stages similar to those of nevi on the skin. Junctional nevi that are first noted in infants, children, and young adults typically mature into compound nevi.
    [Show full text]
  • Melanocytic Lesions of the Conjunctiva
    Melanocytic Lesions of the Conjunctiva Artur Zembowicz, MD, PhD; Rajni V. Mandal, MD; Pitipol Choopong, MD N Context.—Melanocytic proliferations are among the most Data Sources.—Review of the literature and personal common neoplasms of the conjunctiva. They often represent experience of the authors. challenging lesions for pathologists unfamiliar with unique Conclusions.—Classification, state of the art, and prac- histologic features of melanocytic proliferations in this tical aspects of pathology of melanocytic proliferations of location and with nomenclature used by ophthalmologists. the conjunctiva are discussed. Objective.—To comprehensively review clinical aspects, (Arch Pathol Lab Med. 2010;134:1785–1792) pathologic features, and management of melanocytic proliferations of the conjunctiva. elanocytic proliferations are the most common ic proliferations. In contrast, the concept of conjunctival M tumors of the conjunctiva, accounting for up to melanosis and the restricted use of the term melanoma to 53% of all conjunctival neoplasms.1,2 These lesions can be a invasive tumors are unique to the conjunctiva. One of the challenging diagnosis for general pathologists, as both peculiar aspects of this classification scheme is absence of benign and malignant melanocytic proliferations occur- the formal concept of melanoma in situ. All clinically ring in the anatomic context of the conjunctiva produce macular intraepithelial melanocytic proliferations that are unique histologic patterns that are often different from not nevi are included in a broad category of conjunctival those in the skin. Therefore, applying directly the melanosis. Melanosis can be primary or secondary (such histologic criteria developed for cutaneous melanocytic as in Addison disease), and congenital (such as complex- proliferations to these lesions may result in erroneous ion-associated melanosis) or acquired.
    [Show full text]
  • Sialoblastoma of the Sublingual Gland: a Case Report
    Central Journal of Ear, Nose and Throat Disorders Case Report *Corresponding author Ndongo Pilor, Clinique d’ORL et de Chirurgie cervico-faciale, CHU de Fann, Dakar, Sénégal, Tel : Sialoblastoma of the Sublingual 00221775635500; Email: [email protected] Submitted: 06 January 2020 Accepted: 18 January 2020 Gland: A Case Report Published: 20 January 2020 ISSN: 2475-9473 Ndongo Pilor1*, Ciré Ndiaye1, Mame Sanou DIOUF2, Houra Copyright 1 1 Ahmed , and Issa Cheikh NDIAYE © 2020 Pilor N, et al. 1Clinique d’ORL et de Chirurgie cervico-faciale, CHU de Fann, Dakar – Sénégal OPEN ACCESS 2Clinique d’ORL et de chirurgie cervico-faciale, Centre Hospitalier Universitaire Idrissa Pouye de Grand Yoff, Dakar - Sénégal Keywords • Sialoblastoma Abstract • Congenital tumor • Salivary glands Introduction : Sialoblastoma is a rare, congenital malignant epithelial tumor of the • Sublingual gland salivary glands. It is located mainly in the parotid and maxillary glands. Its location in the sublingual gland is exceptional. Summary of the clinical case : We report the case of a 10-month-old infant, with no pathological history, who consulted for a congenital mass under left mandibular, gradually increasing in volume. The examination found a left submandibular mass of about 10 centimeters long axis, firm, mobile compared to the 2 planes, painless with a healthy skin. The cervical CT showed a left mandibular mass, tissue, with regular contours; without lymphadenopathy. The patient had a complete excision of the mass under general anesthesia. Intraoperatively, we found a mass of cerebral aspect extending forward and inward of the left maxillary gland which was normal in appearance. The postoperative course was simple.
    [Show full text]
  • Pathology of the Head and Neck Antonio Cardesa · Pieter J
    Antonio Cardesa · Pieter J. Slootweg (Eds.) Pathology of the Head and Neck Antonio Cardesa · Pieter J. Slootweg (Eds.) Pathology of the Head and Neck With 249 Figures in 308 separate Illustrations and 17 Tables 123 Professor Dr. Antonio Cardesa Department of Pathological Anatomy Hospital Clinic University of Barcelona Villarroel 170 08036 Barcelona Spain Professor Pieter J. Slootweg Department of Pathology University Medical Center St. Radboud P.O. Box 9101 6500 HB Nijmegen The Netherlands Library of Congress Control Number: 2006922731 ISBN-10 3-540-30628-5 Springer Berlin Heidelberg New York ISBN-13 978-3-540-30628-3 Springer Berlin Heidelberg New York This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other way and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under German Copyright Law. Springer is a part of Springer Science+Business Media springer.com © Springer-Verlag Berlin Heidelberg 2006 Printed in Germany The use of general descriptive names, trademarks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and thereof free for general use. Product liability: the publishers cannot guarantee the accuracy of any information about dosage and applica- tion contained in this book.
    [Show full text]
  • Minor Salivary Glands and 'Tubarial Glands'
    J Radiol Clin Imaging 2021; 4 (1): 001-014 DOI: 10.26502/jrci.2809038 Review Article Minor Salivary Glands and ‘Tubarial Glands’-Anatomy, Physiology, and Pathology Relevant to Radiology Sabujan Sainudeen1*, Asmi Sabujan2 1Department of Radiology, Thangam Hospital, Palakkad, Kerala, India 2Department of Radiology, Malabar Scans and Research centre, Tirur, Kerala, India *Corresponding Author: Dr. Sabujan Sainudeen, Department of Radiology, Thangam Hospital, Palakkad, Kerala, India, E- mail: [email protected] Received: 24 December 2020; Accepted: 19 January 2021; Published: 26 January 2021 Citation: Sabujan Sainudeen, Asmi Sabujan. Minor Salivary Glands and ‘Tubarial Glands’-Anatomy, Physiology, and Pathology Relevant to Radiology. Journal of Radiology and Clinical Imaging 4 (2021): 001-014. Abstract review is on the overall current literature of the minor Tubarial glands or tubarial salivary glands are recently salivary glands and tubarial glands-the new entity in reported as a pair of macroscopic salivary glands in the question-along with their potential pathologies. nasopharynx. The remote location of the glands, the rarity Nasopharyngeal glandular origin diseases were reported in of major pathologies involved, and non recognized general as case reports or as small series. This brief review functional significance might have been the reason for the is meant to open up interest in these structures, their non-inclusion before. There are about 500-1000 minor pathologies and encourage further characterization of salivary glands in the body, and most of them are located in diseases of the nasopharynx especially the diseases of the oral cavity or oropharynx. They are small and salivary gland origin. embedded in the aero-digestive tract entrance of the head and neck region.
    [Show full text]
  • Abscess Central Nervous System 465 Periprostatic 322 ACDMPV See
    Cambridge University Press 978-1-107-43080-8 - Essentials of Surgical Pediatric Pathology Edited by Marta C. Cohen and Irene Scheimberg Index More information Index abscess medullary tumors 212–18 arbovirus encephalitis 465 central nervous system 465 neuroblastoma–ganglioneuroma arteriovenous hemangioma 418 periprostatic 322 spectrum 214–18 arteriovenous malformations 25, 418 ACDMPV see alveolar capillary pheochromocytoma 212–14 Aspergillus spp., nasal infection 130 dysplasia with misalignment myelolipoma 218 astroblastoma 446 of pulmonary veins small round-cell tumors 477 astrocytoma acinar cell carcinoma 117–18 adrenal rests 319 anaplastic 442, 443 acinar dysplasia 175, 176 adult granulosa cell tumor 307–8 desmoplastic infantile 446 acinic cell carcinoma 157 aggressive (deep) angiomyxoma 311 diffuse 441–2, 443 acne 1 Alagille syndrome 92, 101 pilocytic 440–1 acromegaly 200 ALCL see anaplastic large T-cell pilomyxoid 441 acute infectious colitis 71–2 lymphoma ataxia telangiectasia 248–9 acute myeloid leukemia 255–9 allele-specific oligonucleotides 481, 485 atopic dermatitis 1–2 classification 255, 257, 258 allergic dermatitis 1 atrophic gastritis 50 clinical presentation 256 alpha-1 antitrypsin deficiency 92, 94, atypical spitzoid neoplasms (ASN) 13 in Down syndrome 260–1 96, 98 atypical teratoid/malignant rhabdoid genetics 258–9 Alport syndrome 352 tumor 451–2 histology 256 alveolar capillary dysplasia with autoimmune gastritis 49–50 acute promyelocytic misalignment of pulmonary autoimmune hepatitis 103 leukemia 259 veins (ACDMPV) 176–7
    [Show full text]